Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Colomer

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 24, 2007
Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancerAlejandro Vazquez-Martin, Ramon Colomer, Javier A Menendez
Current Drug Targets|January 14, 2016
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer AgentsRamon Colomer, Ariadna Sarrats, Ruth Lupu, et al.
Journal of the National Cancer Institute|November 3, 2005
Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogeneJavier A Menendez, Luciano Vellon, Ramon Colomer, et al.
Oncology Reports|May 13, 2004
Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expressionJavier Abel Menendez, Santiago Ropero, Ruth Lupu, et al.
International Journal of Cancer|January 20, 2005
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicityJavier A Menendez, Luciano Vellon, Ramon Colomer, et al.
Oncology Reports|July 29, 2003
Modulation of EGFR and neu expression by n-6 and n-9 high-fat diets in experimental mammary adenocarcinomasRaquel Moral, Montserrat Solanas, Gemma García, et al.
International Journal of Oncology|May 5, 2005
The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survivalJavier A Menendez, Bharvi P Oza, Ramon Colomer, et al.
Academic Radiology|January 11, 2011
3D Assessment of Lymph Nodes vs. RECIST 1.1Sebastian Steger, Fabio Franco, Nicola Sverzellati, et al.
International Journal of Oncology|September 6, 2007
Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cellsAlejandro Vazquez-Martin, Ramon Colomer, Joan Brunet, et al.
Current Drug Targets|May 4, 2016
Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase InhibitorsMaria Jose Bueno, Jesus Sanchez, Ramon Colomer, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|March 24, 2007
Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancerAlejandro Vazquez-Martin, Ramon Colomer, Javier A Menendez
Current Drug Targets|January 14, 2016
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer AgentsRamon Colomer, Ariadna Sarrats, Ruth Lupu, et al.
Journal of the National Cancer Institute|November 3, 2005
Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogeneJavier A Menendez, Luciano Vellon, Ramon Colomer, et al.
Oncology Reports|May 13, 2004
Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expressionJavier Abel Menendez, Santiago Ropero, Ruth Lupu, et al.
International Journal of Cancer|January 20, 2005
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicityJavier A Menendez, Luciano Vellon, Ramon Colomer, et al.
Oncology Reports|July 29, 2003
Modulation of EGFR and neu expression by n-6 and n-9 high-fat diets in experimental mammary adenocarcinomasRaquel Moral, Montserrat Solanas, Gemma García, et al.
International Journal of Oncology|May 5, 2005
The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survivalJavier A Menendez, Bharvi P Oza, Ramon Colomer, et al.
Academic Radiology|January 11, 2011
3D Assessment of Lymph Nodes vs. RECIST 1.1Sebastian Steger, Fabio Franco, Nicola Sverzellati, et al.
International Journal of Oncology|September 6, 2007
Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cellsAlejandro Vazquez-Martin, Ramon Colomer, Joan Brunet, et al.
Current Drug Targets|May 4, 2016
Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase InhibitorsMaria Jose Bueno, Jesus Sanchez, Ramon Colomer, et al.
Pageof 8